Related Experiment Video
Updated: Aug 11, 2026

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Published on: October 29, 2020
The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium
Franziska Fries1,2, Jennifer Herrmann1,2, Michael Dal Molin3,4,5
1Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University, Saarbrücken, Germany.
Abstract:
Despite significant advancements in drug development and discovery, tuberculosis remains one of the world's deadliest infectious diseases. The rise and global spread of multidrug-resistant strains underscore a critical need for new antibiotics with distinct mechanisms of action. Screening of a myxobacterial extract library uncovered the previously unrecognized antitubercular activity of corramycin, a natural product with potent bactericidal activity against both drug-sensitive and -resistant Mycobacterium tuberculosis. Corramycin enters the bacterial cell by exploiting multiple transport systems, and induces DNA double-strand breaks through a novel form of DNA gyrase poisoning. The cryo-electron microscopy structure of M. tuberculosis gyrase in complex with corramycin reveals that the natural product targets a site overlapping with the binding site of synthetic fluoroquinolones, thereby locking the gyrase in an inactive conformation and preventing re-ligation of DNA. Importantly, its unique mode of binding allows corramycin to overcome fluoroquinolone resistance, highlighting its promise as a novel antibiotic scaffold to address the antimicrobial resistance crisis.
Insights
Corramycin, a novel natural product, shows potent activity against drug-susceptible and -resistant tuberculosis strains. It works by uniquely inhibiting DNA gyrase, offering a promising new approach to combatting antimicrobial resistance.
Area of Science:
- Microbiology
- Natural Product Chemistry
- Drug Discovery
Background:
- Tuberculosis remains a leading global infectious disease, with rising multidrug-resistant strains necessitating novel antibiotics.
- Existing treatments face challenges due to resistance, highlighting the urgent need for new therapeutic strategies with distinct mechanisms of action.
Purpose of the Study:
- To identify and characterize novel antitubercular compounds from natural sources.
- To investigate the mechanism of action and structural basis for the activity of corramycin against Mycobacterium tuberculosis.
Main Methods:
- Screening of a myxobacterial extract library for antitubercular activity.
- Determination of corramycin's mechanism of action, including its effect on DNA gyrase.
- Cryo-electron microscopy to elucidate the structural complex of Mycobacterium tuberculosis gyrase and corramycin.
Main Results:
- Corramycin exhibits potent bactericidal activity against both drug-sensitive and multidrug-resistant Mycobacterium tuberculosis strains.
- Corramycin induces DNA double-strand breaks by a novel mechanism of DNA gyrase poisoning.
- Structural analysis reveals corramycin binds to a unique site on DNA gyrase, distinct from fluoroquinolones, overcoming existing resistance.
Conclusions:
- Corramycin is a promising natural product with potent antitubercular activity and a novel mechanism of action.
- Its ability to overcome fluoroquinolone resistance makes it a valuable scaffold for developing new antibiotics against tuberculosis.
- This discovery offers a potential new avenue to address the global crisis of antimicrobial resistance.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Clinical Significance of Antibiotic Resistance

